Stuart W. Peltz

2016

In 2016, Stuart W. Peltz earned a total compensation of $4.2M as Chief Executive Officer at PTC Therapeutics, a 60% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$260,000
Option Awards$3,354,908
Salary$618,000
Other$9,603
Total$4,242,510

Peltz received $3.4M in option awards, accounting for 79% of the total pay in 2016.

Peltz also received $260K in non-equity incentive plan, $618K in salary and $9.6K in other compensation.

Rankings

In 2016, Stuart W. Peltz's compensation ranked 2,041st out of 14,075 executives tracked by ExecPay. In other words, Peltz earned more than 85.5% of executives.

ClassificationRankingPercentile
All
2,041
out of 14,075
86th
Division
Manufacturing
701
out of 5,488
87th
Major group
Chemicals And Allied Products
203
out of 1,900
89th
Industry group
Drugs
146
out of 1,543
91st
Industry
Pharmaceutical Preparations
118
out of 1,173
90th
Source: SEC filing on April 27, 2017.

Peltz's colleagues

We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2016.

2016

Shane Kovacs

PTC Therapeutics

Chief Financial Officer

2016

Mark Rothera

PTC Therapeutics

Chief Commercial Officer

2016

Mark Boulding

PTC Therapeutics

Chief Legal Officer

2016

Neil Almstead

PTC Therapeutics

Executive Vice President, Research, Pharmaceutical Operations & Technology

News

In-depth

You may also like